ORAMED PHARMACEUTICALS INC. Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31)
ORAMED PHARMACEUTICALS INC. (ORMP) reported Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) of -$43.00 thousand for the 9-month period ending 2018-05-31, per its 10-Q filed 2018-07-12.
Discontinued › Income Statement › Other Income
us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGainLoss1 · last filed 2018-07-12
- ORAMED PHARMACEUTICALS INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2018-05-31 was $10.00K.
- ORAMED PHARMACEUTICALS INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2018-02-28 was -$24.00K.
- ORAMED PHARMACEUTICALS INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for the quarter ending 2017-11-30 was -$29.00K.
- ORAMED PHARMACEUTICALS INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for fiscal 2016 was $1.00K.
- ORAMED PHARMACEUTICALS INC. available-for-sale securities, gross unrealized gain (loss) (deprecated 2018-01-31) for fiscal 2015 was -$4.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 6 month | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 9 month | Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-05-31 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-12 | -$14.00K derived: sum of 2 quarters · filed 2018-07-12 | -$43.00K 10-Q · filed 2018-07-12 | |
| 2018-02-28 | -$24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-09 | -$53.00K 10-Q · filed 2018-04-09 | ||
| 2017-11-30 | -$29.00K 10-Q · filed 2018-01-11 | |||
| 2017-08-31 | -$1.00K 10-Q · filed 2018-07-12 | |||
| 2016-08-31 | $1.00K 10-K · filed 2017-11-29 | |||
| 2015-08-31 | -$4.00K 10-K · filed 2016-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |